UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Annals of oncology, 2019-06, Vol.30 (6), p.921-926

2019

Volltextzugriff (PDF)

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Annals of oncology, 2019-03, Vol.30 (3), p.418-423

2019

Volltextzugriff (PDF)

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29, p.viii63-viii63

2018

Volltextzugriff (PDF)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29, p.viii58-viii59

2018

Volltextzugriff (PDF)

Sentinel lymph node biopsy and Axillary dissection in breast cancer : Results in a large series

JNCI : Journal of the National Cancer Institute, 1999-02, Vol.91 (4), p.368-373

1999

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi31

2017

Volltextzugriff (PDF)

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi27

2017

Volltextzugriff (PDF)

Well-differentiated liposarcoma (atypical lipomatous tumors)

Seminars in diagnostic pathology, 2001-11, Vol.18 (4), p.258

2001

Volltextzugriff (PDF)

239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial

Annals of oncology, 2024-09, Vol.35, p.S313-S313

2024

Volltextzugriff (PDF)

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Pathologica, 2012-12, Vol.104 (6), p.428

2012

Volltextzugriff (PDF)

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-04

2019

Volltextzugriff (PDF)

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Annals of oncology, 2020-05, Vol.31, p.S23-S23

2020

Volltextzugriff (PDF)

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

Seminars in diagnostic pathology, 2001-11, Vol.18 (4), p.267

2001

Volltextzugriff (PDF)

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

Annals of oncology, 2017-09, Vol.28, p.v63-v63

2017

Volltextzugriff (PDF)

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

Annals of oncology, 2012-09, Vol.23, p.ix124

2012

Volltextzugriff (PDF)

186OTumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-05-20

2017

Volltextzugriff (PDF)

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-06

2017

Volltextzugriff (PDF)

Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients

Cancer, 1999-06, Vol.85 (11), p.2433-2438

1999

Volltextzugriff (PDF)

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Annals of oncology, 2016-10, Vol.27, p.vi53-vi53

2016

Volltextzugriff (PDF)

Abstract P1-13-02: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-13-02

2018

Volltextzugriff (PDF)

Rabbit monoclonal antibodies a comparative study between : A novel category of immunoreagents and the corresponding mouse monoclonal antibodies

American journal of clinical pathology, 2005-08, Vol.124 (2), p.295-302

2005

Volltextzugriff (PDF)

Wegener’s granulomatosis confined to nervous system

BMJ case reports, 2008, Vol.2008 (nov12 1), p.bcr0620080283-bcr0620080283

2008

Volltextzugriff (PDF)

Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

Annals of oncology, 1999-08, Vol.10 (8), p.993-996

1999

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Sentinel lymph node biopsy and Axillary dissection in breast cancer : Results in a large series

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)

Well-differentiated liposarcoma (atypical lipomatous tumors)

239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up

Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease

19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study

Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model

New Immunohistochemical Markers Predictive of Response to Neoadjuvant Chemotherapy Plus Trastuzumab in HER2-Positive Locally Advanced Breast Cancer: A Single Center Experience

186OTumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

Abstract P2-05-20: Tumor infiltrating lymphocytes in recurrent HER2+ and triple negative breast cancer: Prognostic value according to tumor phenotype

Abstract P1-12-06: Factors related to the prognosis of breast cancer patients after the development of brain metastases

Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients

First prospective multicenter Italian study on the impact of the 21-gene recurrence score® (RS) in adjuvant clinical decisions for ER + /HER2- early breast cancer patients

Abstract P1-13-02: Withdrawn

Rabbit monoclonal antibodies a comparative study between : A novel category of immunoreagents and the corresponding mouse monoclonal antibodies

Wegener’s granulomatosis confined to nervous system

Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)

Aktive Filter

Suchergebnisse filtern